Agneta Henriette Snoer, MD, PhD

H. Lundbeck A/S, Valby, Denmark
Copenhagen, Denmark

Disclosure information not submitted.

Presentation(s):

• ORF49-05 - Results from a Phase 1b Trial Evaluating CD40-Ligand Blocker Lu AG22515 in Patients with Moderate-to-Severe Thyroid Eye Disease

  Monday, June 15, 2026
  2:15 PM - 2:30 PM CT